A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 496.44
C 32.98
GOOG 607.08
BAC 8.10
RIMM 15.60

Recently Added

CPIC 1.17
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.72

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.17
NBTH 12.50
IDVC 0.35
3.30 -0.20 (-5.80%) VICL

Click Here to Receive Instant E-mail and RSS Alerts


Trade VICL now with

Stock Details

Last Trade:3.30 Change:-0.20 (-5.80%) Prev Close:3.50 Open: 3.45 Days Range:3.30 – 3.46 52 Week Range: 1.70 - 5.30 Volume:841197 P/E: N/A
EPS:-0.11





Recent Blog Posts

Blog Posts on 02/09/12 at 10:31am
Vical's Herpes Vaccine Headed To The Clinic
Blog Posts on 02/08/12 at 4:40pm
Vical's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Blog Posts on 02/03/12 at 1:18pm
Vical Inc.: A $3 Biotech Lottery Ticket I Am Buying Now
Blog Posts on 01/31/12 at 10:45am
Vical's Allovectin: If Approved, What Kind Of Launch Can Be Expected?
Blog Posts on 01/25/12 at 4:02pm
2011 Review And Outlook For Biotechnology In 2012
Blog Posts on 01/25/12 at 11:40am
Immunotherapy Cancer Trials With Key Data Due In 2012
Blog Posts on 01/15/12 at 6:44am
4 Stocks Seeing Major Insider Buying In January
Blog Posts on 01/13/12 at 12:41pm
4 Stocks With Heavy Insider Buying
Blog Posts on 01/12/12 at 6:07pm
Investing In Flu-Fighting Drug Makers
Blog Posts on 01/11/12 at 1:32pm
Vical: TransVax Therapeutic Vaccine Phase 2 Trial Results Published
Blog Posts on 01/10/12 at 4:22pm
Analyzing Monday's Noteworthy Insider Buys And Sells
Blog Posts on 01/09/12 at 1:52pm
Vical: A Review Of, And Update On, Allovectin
Blog Posts on 01/08/12 at 4:27am
Analyzing Friday's Noteworthy Insider Buys And Sells
Blog Posts on 01/06/12 at 6:03am
5 Biotech Stocks Deeply Discounted From Target Price
Blog Posts on 01/03/12 at 12:25pm
6 'Coiled Spring' Biotech Stocks To Consider In 2012
Blog Posts on 12/19/11 at 1:20pm
Q3 Small-Cap Biotech Picks By The World's Largest Fund Managers
Blog Posts on 12/15/11 at 11:17am
2012 Preview: Cancer Immunotherapy Catalysts
Blog Posts on 12/13/11 at 3:21am
17 Stocks Under $5 Being Bought Up By Hedge Funds
Blog Posts on 12/06/11 at 12:59pm
Short-Term Limits For 8 Small Cap Movers
Blog Posts on 11/16/11 at 4:37am
Vical Incorporated at Credit Suisse Group Healthcare Conference Call Transcript
Blog Posts on 11/08/11 at 5:31pm
IPO Preview: NewLink Genetics
Blog Posts on 11/04/11 at 6:56pm
Vical Back On The Move
Blog Posts on 11/01/11 at 3:42pm
Vical Incorporated's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Blog Posts on 11/01/11 at 10:32am
Vical: All Systems Are Go
Blog Posts on 10/13/11 at 4:12pm
What A Nobel Prize Winner Knew And Savvy Biotech Investors Should
Blog Posts on 09/30/11 at 12:08pm
Vical's Allovectin-7: Are The Phase 3 Trial Results Hiding In Plain Sight?
Blog Posts on 09/23/11 at 11:57am
5 Stocks Acting Strong In A Weak Market
Blog Posts on 09/20/11 at 5:27pm
Adjuvants May Hold Key To Unlocking Cancer Immunotherapy Revolution
Blog Posts on 08/26/11 at 10:48pm
Vical: Making Progress In The Area Of HSV-2 Vaccines
Blog Posts on 08/03/11 at 6:46pm
Vical's CEO Discusses Q2 2011 Results - Earnings Call Transcript